Effects of patients' preferences on the treatment of atrial fibrillation: Observational study of patient-based decision analysis

Western Journal of Medicine

Volumn 174, Issue 5, 2001, Pages 311-315

  Protheroe, Joanne ^a   Fahey, Tom ^a   Montgomery, Alan A ^a   Peters, Tim J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; COMORBIDITY; DATA ANALYSIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRESCRIPTION; RISK; THROMBOEMBOLISM; UNITED KINGDOM;

EMPIRICAL APPROACH; PROFESSIONAL PATIENT RELATIONSHIP;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVALS; DECISION SUPPORT TECHNIQUES; ENGLAND; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PROBABILITY; QUESTIONNAIRES; RISK ASSESSMENT; SAMPLING STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 0034998467     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.174.5.311     Document Type: Article

References (30)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intent Med 1994;154:1449-1457.
2. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352:1167-1171.
3. Fahey T, Rimmer J, Godfrey P. Risk stratification in the management of atrial fibrillation in the community. Br J Gen ract 1999;49:295-296.
4. Sweeney KG, Gray DP, Steele R, Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract 1995;45:153-158.
5. Sweeney KG, Pereira Gray DJ, Steele RJ, Evans PH. Caution needed in introducing warfarin treatment [commentary]. BMJ 1995;311:560-501.
6. Lilford RJ, Pauker SG, Braunholtz DA, Chard J. Decision analysis and the implementation of research findings. BMJ 1998;317:405-409.
7. Nease RF, Tsai R, Hynes LM, Littenberg B. Automated utility assessment of global health, Qual Life Res 1996;5:175-182.
8. Howitt A, Armstrong D. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ 1999;318:1324-1327.
9. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995;108(suppl):352S-359S.
10. Glasziou P, Irwig L. An evidence based approach to individualising treatment. BMJ 1995;311:1356-1359.
11. Lip GYH. Thromboprophylaxis for atrial fibrillation. Lancet 1999;353:4-6 [erratum published in Lancet 1999;353:1978].
12. Lip GYH. Thromboprophylaxis for atrial fibrillation. Lancet 1999;353:4-6 [erratum published in Lancet 1999;353:1978].
13. Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study ot 1066 patients from 3 clinical trials. Arch Intern Med 1998;158:1316-1320.
14. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire community stroke project - 1981-1986. 2. Incidence, case fatality rates and overall outcome of one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:16-22.
16. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-46.
17. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
18. Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy 1997;2:112-121.
19. Man-Son-Hing M, Laupacis A, O'Connor AM, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA 1999;282:737-743.
20. English KM, Channer KS. Managing atrial fibrillation in elderly people [editorial]. BMJ 1999;318:1088-1089.
21. Hlatky M. Patient preferences and clinical guidelines [editorial]. JAMA 1995;273:1219-1220.
22. Thomson R, Partin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulation therapy to prevent stroke in patients with atrial fibrillation, Lancet 2000;355:956-962 [erratum published in Lancet 2000;355:1466].
23. Thomson R, Partin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulation therapy to prevent stroke in patients with atrial fibrillation, Lancet 2000;355:956-962 [erratum published in Lancet 2000;355:1466].
24. Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med 1991;151:1944-1949 [erratum published in Arch Intent Med 1992;152:825].
25. Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med 1991;151:1944-1949 [erratum published in Arch Intent Med 1992;152:825].
26. Gullov AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation - the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med 1999;159:1322-1328.
27. O'Connor AM, Rostom A, Fiset V, et al. Decison aids for patients facing health treatment or screening decisions: systematic review. BMJ 1999;319:731-734.
28. Edwards A, Elwyn G. Fhe potential benefits of decision aids in clinical medicine [editorial]. JAMA 1999;282:779-780.
29. Clancy CM, Cebul RD, Williams SV. Guiding individual decisions: a randomized, controlled trial of decision analysis. Am J Med 1988;84:283-288.
30. Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: part 3 - estimating probabilities and utilities. Med Decis Making 1997;17:136-141.